MIRA PHARMACEUTICALS, INC. (MIRA)
↓ Download CSVKey ratios (FY2025)
-100.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net Income | -$10.44M | -$7.85M | -$11.98M | -$7.06M |
| EPS (Diluted) | $-1.35 | $-0.51 | $-0.85 | $-0.40 |
| Total Assets | $11.09M | $2.92M | $4.93M | $858.1K |
| Total Liabilities | $702.1K | $723.3K | $558.1K | $1.45M |
| Shareholders' Equity | $10.39M | $2.20M | $4.37M | -$596.2K |
| Cash & Equivalents | $6.35M | $2.83M | — | — |
| Operating Cash Flow | -$4.66M | -$5.56M | -$4.53M | -$5.60M |
| Shares Outstanding | 41.94M | 16.56M | 14.78M | 13.31M |